Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,067 | 135 | 99.4% |
| Education | $11.65 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $471.74 | 33 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $304.58 | 29 | $0 (2019) |
| Amgen Inc. | $234.41 | 11 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $190.03 | 5 | $0 (2019) |
| Novo Nordisk Inc | $182.15 | 18 | $0 (2020) |
| GlaxoSmithKline, LLC. | $146.53 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $144.19 | 5 | $0 (2019) |
| Janssen Biotech, Inc. | $83.06 | 10 | $0 (2019) |
| Astellas Pharma US Inc | $72.04 | 6 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $65.28 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $30.68 | 2 | Novo Nordisk Inc ($16.17) |
| 2019 | $670.23 | 40 | Amgen Inc. ($194.73) |
| 2018 | $1,058 | 80 | PFIZER INC. ($263.65) |
| 2017 | $319.63 | 15 | PFIZER INC. ($160.07) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 07/16/2020 | Philips Electronics North America Corporation | (7999) SRC Undivided (Device) | Food and Beverage | Cash or cash equivalent | $14.51 | General |
| Category: Devices | ||||||
| 08/26/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/02/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2019 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Neuroscience | ||||||
| 06/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/14/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Neuroscience | ||||||
| 05/07/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $3.23 | General |
| Category: Cardiovascular | ||||||
| 05/06/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Obesity | ||||||
| 05/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/30/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: RESPIRATORY | ||||||
| 04/23/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.30 | General |
| Category: Cardiovascular | ||||||
| 04/23/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.14 | General |
| Category: Cardiovascular | ||||||
| 04/22/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological), Vyvanse, Trintellix | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Lower GI | ||||||
| 04/18/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 04/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/29/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Neuroscience | ||||||
| 03/28/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/27/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: UROLOGY | ||||||
| 03/20/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: Neuroscience | ||||||
| 03/14/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $113.40 | General |
| Category: Neuroscience | ||||||
| 03/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 666 | 855 | $172,998 | $49,902 |
| 2022 | 13 | 652 | 756 | $123,341 | $43,569 |
| 2021 | 8 | 280 | 402 | $53,042 | $27,085 |
| 2020 | 3 | 63 | 72 | $18,840 | $5,588 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 249 | $76,175 | $20,824 | 27.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 83 | 83 | $27,454 | $10,163 | 37.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $18,275 | $4,809 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 69 | $14,376 | $3,488 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 24 | $9,888 | $2,979 | 30.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 40 | $10,600 | $2,877 | 27.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 136 | 205 | $3,618 | $1,722 | 47.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $4,050 | $1,288 | 31.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,366 | $814.73 | 24.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $1,530 | $486.71 | 31.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 33 | $2,420 | $314.16 | 13.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 53 | 62 | $1,246 | $136.40 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 181 | 222 | $54,697 | $18,143 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 152 | $23,995 | $8,511 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 34 | 34 | $7,908 | $4,218 | 53.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 49 | 49 | $11,270 | $3,290 | 29.2% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 19 | 20 | $8,560 | $2,796 | 32.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 28 | 28 | $3,780 | $2,275 | 60.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 52 | 52 | $4,680 | $1,418 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,184 | $1,271 | 39.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 28 | 28 | $728.00 | $490.06 | 67.3% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 13 | 13 | $663.00 | $470.08 | 70.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 34 | 44 | $2,660 | $402.75 | 15.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 66 | 77 | $696.00 | $226.56 | 32.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 23 | 26 | $520.00 | $57.20 | 11.0% |
About Dr. Sumit Som, M.D
Dr. Sumit Som, M.D is a Family Medicine healthcare provider based in Clarksville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2014. The National Provider Identifier (NPI) number assigned to this provider is 1235559451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sumit Som, M.D has received a total of $2,079 in payments from pharmaceutical and medical device companies, with $30.68 received in 2020. These payments were reported across 137 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,067).
As a Medicare-enrolled provider, Som has provided services to 1,661 Medicare beneficiaries, totaling 2,085 services with total Medicare billing of $126,143. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Clarksville, IN
- Active Since 04/27/2014
- Last Updated 07/22/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1235559451
Products in Payments
- ELIQUIS (Drug) $378.85
- XARELTO (Drug) $228.77
- Aimovig (Biological) $207.28
- FARXIGA (Drug) $173.27
- CHANTIX (Drug) $172.45
- SHINGRIX (Biological) $123.22
- INVOKANA (Drug) $75.81
- Victoza (Drug) $63.52
- Saxenda (Drug) $58.43
- JARDIANCE (Drug) $49.38
- Ozempic (Drug) $48.02
- Symtuza (Drug) $45.53
- PREZCOBIX (Drug) $37.53
- VIAGRA (Drug) $34.38
- VESICARE (Drug) $28.61
- MYRBETRIQ (Drug) $22.33
- TRIUMEQ (Drug) $21.96
- Myrbetriq (Drug) $21.10
- Xofluza (Drug) $20.59
- LYRICA (Drug) $18.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clarksville
Patricia Isaacs, M.d, M.D
Family Medicine — Payments: $54,287
Dr. Carlo Pike, D.o, D.O
Family Medicine — Payments: $15,761
Dr. David Boles, Do, DO
Family Medicine — Payments: $15,467
Dr. Scott Kuykendall, M.d, M.D
Family Medicine — Payments: $11,968
Dr. William Williams, D.o, D.O
Family Medicine — Payments: $11,059
Roxanne Marshall, M.d, M.D
Family Medicine — Payments: $10,915